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Abstract 
Background.  Constipation can lead to serious health issues and death. This systematic review 
summarises international research pertaining to the management of constipation in people 
with intellectual disability.   
Method.  Studies published from 1990 to 2017 were identified using Medline, Cinahl, 
PsycINFO, Web of Science, email requests, and cross-citations. Studies were reviewed 
narratively in relation to identified themes. 
Results.  18 studies were reviewed in relation to three themes: laxative receipt; interventions 
(dietary fibre, abdominal massage and macrogol); and staff issues (knowledge and training).    
Laxative polypharmacy was common.  Studies report positive results for dietary fibre and 
abdominal massage although study quality was limited. 
Conclusion.  The main management response to constipation in people with intellectual 
disability is laxative use despite limited effectiveness.  An improved evidence base is 
required to support the suggestion that an individualised, integrated bowel management 
programme may reduce constipation and associated health conditions in people with 




Constipation is a syndrome defined by bowel symptoms of difficult or infrequent 
passage of stool, hardness of stool, or a feeling of incomplete evacuation (Bharucha et al., 
2013).  Constipation can be classified as primary constipation (also referred to as chronic 
idiopathic constipation (CIC) or functional constipation) and secondary constipation 
(attributed to comorbid medical conditions or medications) (Sbahi and Cash, 2015).   
The concept of constipation is complicated by disagreement among patients and 
doctors about its nature (Longstreth et al., 2006).   Whilst physicians often regard 
constipation to be synonymous with infrequent bowel movements (usually less than three 
times a week), patients may have a broader set of symptoms, as while bowel movement 
infrequency can be distressing to patients it is the quality of, or difficulty associated with, 
defecation that is the primary determinant of patient-described constipation (Sbahi and Cash, 
2015).  As such, the Rome III diagnostic criteria for functional constipation (Longstreth et al., 
2006) incorporates symptoms such as ‘sensation of incomplete evacuation for at least 25% of 
defecations’, and ‘straining during at least 25% of defecations’.   
The complications of chronic constipation can be serious and life-threatening, 
including: faecal incontinence (where overflow incontinence may confuse the diagnosis of 
chronic constipation); haemorrhoids; anal fissure; pelvic organ prolapse;  faecal impaction 
and bowel obstruction necessitating surgery; and bowel perforation and stercoral peritonitis 
where extremely impacted faeces can compress the colonic wall, causing an ischemic ulcer 
and subsequent perforation, culminating in stercoral peritonitis and sometimes death (Leung 
et al., 2011, Serrano Falcón et al., 2016).  Faecal impaction can also lead to megacolon 
(Serrano Falcón et al., 2016).    Further, the impairment in health related quality of life 
(HRQoL) observed in adults with constipation is comparable with that seen in conditions that 
might be regarded as more ‘serious’, such as osteoarthritis, rheumatoid arthritis, chronic 
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allergies and diabetes (Belsey et al., 2010).  In children, the level of impairment seen is 
greater than with gastro-oesophageal reﬂux and inﬂammatory bowel disease  (Belsey et al., 
2010).  Early detection and management are crucial (De Hert et al., 2011).   
There are a number of reasons underlying a need to focus on constipation in people 
with intellectual disability.  The usual trigger for doctors to consider constipation is the 
specific mention of constipation by the patient or the communicated history of abdominal 
symptoms, but patients with intellectual disability may be unable to communicate these 
(Coleman and Spurling, 2010).   In people with intellectual disability, pain from constipation 
may present as distress, sleep disturbance or behavioural changes (Coleman and Spurling, 
2010), and may be associated with behavioural problems such as aggression and self-injury 
(Bosch et al., 1997, Christensen et al., 2009, Carr and Smith, 1995). As a result, constipation 
may be missed. 
Constipation can have serious consequences for people with intellectual disability if it 
is not identified and managed appropriately.  Constipation constitutes an ambulatory care 
sensitive condition (ACSC) for people with intellectual disability (Balogh et al., 2011).  A 
Canadian study on hospitalisation rates for ACSCs found that the hospitalisation rate for 
constipation for people with intellectual disability was 7.9 times higher (95% CI 4.4, 14.2) 
than for people without an intellectual disability (Balogh et al., 2010).  In England, 
constipation was found to be one of the common causes of emergency hospital admissions for 
ACSCs (Glover and Evison, 2013).  Constipation can also lead to death.  The Safeguarding 
Adults Board in Suffolk, England, commissioned two Serious Case Reviews in early 2014 
into the deaths of two people with intellectual disability (Flynn and Eley, 2015b, Flynn and 
Eley, 2015c), both of whom died from complications arising from constipation (Flynn and 
Eley, 2015a).   
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Several factors put people with intellectual disability at increased risk of constipation.  
Many medicines are constipating (NICE, 2015) and people with intellectual disability are 
more likely to be prescribed some of these.  For example, constipation is a common side 
effect of different antipsychotics (De Hert et al., 2011) and people with intellectual disability 
are much more likely than others to be prescribed anti-psychotic medications (Glover et al., 
2015). Progression from constipation to ileus, intestinal obstruction, bowel ischaemia, 
megacolon and death is not uncommon, particularly  in patients (not necessarily with 
intellectual disability) prescribed clozapine (Every-Palmer et al., 2017).  People with 
intellectual disability are also more likely to have poor diet (Humphries et al., 2009), physical 
mobility limitations (Cleaver et al., 2009), and low levels of physical activity (Emerson, 
2005, Robertson et al., 2000), all factors associated with constipation (Mugie et al., 2011). 
People with Down syndrome are more likely to have hypothyroidism (Goday-Arno et al., 
2009) which is associated with constipation (NICE, 2015).  
This increased risk is reflected in findings of a high prevalence of constipation in 
people with intellectual disability.  A recent systematic review on the prevalence of 
constipation in people with intellectual disability identified 31 relevant studies, of which 14 
reported constipation rates of 50% or more, and 21 reported rates over 33% (Robertson et al., 
2017).  Constipation was more common in those with cerebral palsy and profound intellectual 
disability, and associated with immobility but not age, suggesting that constipation is a 
significant issue for people with intellectual disability across the life course.  In a further 
recent study, of 99 people with severe or profound intellectual and motor disabilities, 94% 
had constipation (van Timmeren et al., 2016).   
In view of the serious potential consequences of constipation and the high prevalence 
of constipation, there is a clear need to consider how services should respond in order to 
effectively manage constipation in people with intellectual disability.  The aforementioned 
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review included studies of laxative use as an indicator of constipation and it is clear that rates 
of laxative use are high and likely to constitute the predominant management response to 
constipation in this population.  Based on the most representative study which included 868 
people with intellectual disability and 4,305 controls, over 25% of people with intellectual 
disability received a repeat prescription for laxatives in one year, compared to 0.1% of people 
without intellectual disability (Straetmans et al., 2007).  Of nearly 3,000 adults and children 
with Down syndrome, the one year prevalence of laxative prescription was 18.8% compared 
to 3.4% of 8,910 matched controls (Alexander et al., 2015).  Of 254 people with profound 
intellectual and multiple disabilities, 65.0% had been prescribed laxatives in the previous year 
(van der Heide, van der Putten, van den Berg, Taxis, & Vlaskamp, 2009).  Other figures for 
laxative use included: 73.1% of 26 females with profound intellectual disability (Giesbers et 
al., 2012), 65% of 55 institutionalized adults with profound intellectual disability (Kozma and 
Mason, 2003), 43.3% of 806 people aged 50+ known to intellectual disability services 
(Hermans and Evenhuis, 2014), and 26.4% of 254 people with moderate to profound 
intellectual disability living in institutions (Van Winckel et al., 1999).    
However, the reliance on laxatives as a management response may be inappropriate.  
Clinical trials show that most laxatives achieve poor results (Jiang et al., 2015). Many 
community-based patients (not necessarily with intellectual disability) have poorly controlled 
constipation despite receiving laxatives regularly, with complex, ineffective and/or 
inappropriate laxative prescribing linked to sub-optimal bowel care (Addison et al., 2003).  
Whilst further studies are required, there is also some evidence that long term laxative use 
may be linked to colorectal cancer (Watanabe et al., 2004), particularly with respect to  non-
fibre laxatives (Citronberg et al., 2014).  There are also potential hazards of mineral oil use 
for chronic constipation in relation to lipoid pneumonia (Bandla et al., 1999).   
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The objective of this paper is to present the first systematic review of international 
research pertaining to the management of constipation in people with intellectual disability.  
The review aims to summarise research on how constipation is currently managed, the 
effectiveness of interventions for constipation, and service related issues such as staff 
knowledge and training.   
Method 
The review was conducted in accordance with PRISMA guidelines (Moher et al., 
2009).  Electronic literature database searches were conducted in Medline, Cinahl and 
PsycINFO (all on EBSCO) and Web of Science (Core Collection) in January 2016 and 
subsequently updated on March 7th 2017.  Searches combined terms for constipation and 
intellectual disability with the Boolean operator ‘and’.   An example of database specific 
search terms (Medline) is given in Appendix One. Searches included broad terms relating to 
constipation and people with intellectual disability. Specific inclusion and exclusion criteria 
relating to constipation management were applied as below.   The reference lists of studies 
meeting the inclusion criteria were searched.  In addition, in December 2015 a request for 
information on research relevant to the review was sent to members of the International 
Association for the Scientific Study of Intellectual and Developmental Disabilities 
(IASSIDD) Health Special Interest Research Group and the Intellectual Disability UK 
Research mailing list.   
Inclusion Criteria 
Articles were required to meet all the following criteria: 
 Peer reviewed 
 English language full text 
 Published from 1990 to March 7th 2017 
 Quantitative research, evaluation or audit, or qualitative research 
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 Samples where 50% or more have intellectual disability or mixed samples where 
results are disaggregated for people with intellectual disability 
 Includes data regarding the current management of constipation (including type of 
laxatives prescribed), intervention effectiveness, or service related issues such as staff 
training or knowledge of carers regarding constipation 
Exclusion Criteria 
 Not peer reviewed or peer review status unclear 
 Any study employing any research design with a sample size of less than 10 
 Reviews, letters, commentaries, editorials, meeting or conference abstracts 
 Studies based on neonates (new born infants up to 28 days after birth)  
 Studies on conditions where intellectual disability cannot be assumed (e.g. cerebral 
palsy) where results not disaggregated for people with intellectual disability 
 Studies on specific syndromes associated with intellectual disability with the 
exception of Down syndrome, which is the most common genetic cause of intellectual 
disability (Sherman et al., 2007).   Less common specific syndromes such as Rett 
syndrome were excluded although it is evident that some research on such syndromes 
exists (e.g. Baikie et al., 2014, Schwartzman et al., 2008) 
 Studies relating to medication as an intervention where use of the medication is not 
supported by current knowledge or constipation management guidelines (NICE, 2010, 
NICE, 2015).  
 Studies only presenting information on the percentage of people with intellectual 
disability who receive laxative medication as this is covered in an existing review 
(Robertson et al., 2017) 
 Studies relating to encopresis (soiling)  
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 Studies relating to Hirschsprung’s disease and Down syndrome, as a meta-analysis of 
61 studies relating to incidence, outcomes and mortality already exists (Friedmacher 
and Puri, 2013). 
 
Initially, titles and abstracts were used to exclude studies which were obviously not 
within scope (first author).  Those retained for further screening were those for which 
relevance could not be assessed without accessing full text, or those that were chosen as 
potentially within scope. These studies were screened by the first and last author and 
discussed until consensus was reached on whether or not they met the inclusion criteria.  All 
relevant studies were included in the review regardless of methodological quality.  Study data 
was extracted from full text articles and entered into an excel database with regard to: 
authors, year, country, main focus of study, study design, sample source, key sample features, 
sample size, sample age range (mean, SD and median), sample living situation, percentage of 
sample male, measures employed, and management related results.   
Quality Assessment/Risk of Bias 
Study quality was assessed using the Mixed Methods Appraisal Tool (MMAT) which 
was designed for the appraisal stage of systematic reviews that include qualitative, 
quantitative and mixed method studies and allows reviewers to concomitantly appraise most 
common types of study methodology and design (Pluye et al., 2011).  In the MMAT, primary 
studies (or mixed method study components) are rated in relation to four specific 
methodological quality criteria depending on study type: qualitative; quantitative randomized 
controlled (trials); quantitative non-randomized; or quantitative descriptive studies.  The 
number of the criteria met is reported in the form of an asterix (*) for each criterion met. For 
quasi-experimental designs not employing a control group (scored using the criteria for 
quantitative non-randomized studies) a criterion relating to comparability of groups was not 
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applicable hence these studies could not attain a score greater than 3* out of 4*.  The MMAT 
is an efficient tool, but reliability needs further improvement, particularly for two items 
relating to qualitative studies including the sentence ‘appropriate consideration’ (Souto et al., 
2015).   
Identification of Themes   
An iterative approach was taken in which a list of themes was identified by the first 
author via reading and re-reading the study summaries in Excel and these themes were 
allocated to overarching themes  (Braun and Clarke, 2006). The themes and overarching 
themes identified were entered into the Excel database for each study.  These were then 
checked by the last author and discussed until consensus was reached.  Results were collated, 
summarised and reported via a tabulation of key data, descriptive numerical summary of 
included studies (e.g. number with particular research designs) and a descriptive narrative 
summary of the identified themes.    
All extracted data in Excel was subsequently checked for accuracy and completeness 
by the last author.  MMAT ratings and theme allocation were also checked by the last author.  
Whilst a third reviewer was available to resolve any disagreements, no instances of 
disagreement arose.    
It was not possible to compare results between studies directly due to variation in the 
methods used, and therefore a meta-analysis was not conducted. 
Results 
The process of identifying studies for inclusion is summarised in Figure 1.  Searches 
identified 1,929 articles, with 1,279 remaining following deletion of 650 duplicates.  1,169 
articles were excluded based on the title/abstract, leaving a pool of 110 articles for further 
screening.  After examination of full text and the addition of articles cited within these and 
from other sources, 18 articles met the criteria for inclusion, none of which were based on 
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data from the same study giving a total of 18 studies. Studies are summarised in Table 1 
which lists studies from the oldest to the most recent in order to help elucidate temporal 
trends.   Studies are reviewed narratively below in relation to three themes (one study 
contributes to two themes): laxative types; interventions (dietary fibre, abdominal massage 
and macrogol); and staff issues (knowledge and training).  A further two studies on 
medication were identified but these were excluded as they are not included in current 
constipation management guidelines. One study looked at Cisapride (Staiano et al., 1996) but 
this has now been withdrawn from most of the world's health institutes because of its 
recorded fatalities in addition to serious side effects such as severe arrhythmias 
(Aboumarzouk et al., 2011).  The second study looked at Colchicine (Frame et al., 1998) 
which has been associated with increased occurrence of abdominal pain, and long-term use 
may cause granulocytopenia, renal dysfunction, reversible myopathy or neuropathy and 
hepatitis (Jiang et al., 2015). 
Geography 
All studies were from high income countries: four from England, three from the 
Netherlands, two from Belgium, two from the United States, and one each from Australia, 
France, Hong Kong, Ireland, Italy, Scotland, and Wales.   
MMAT Quality Appraisal 
Information on MMAT types and scores is given in the first column of Table 1.  Only 
one study met all MMAT criteria, four scored 3*, 10 scored 2*, three scored 1*, and one 
study did not meet any criteria due to a lack of reported methodological detail. The most 
common unmet criteria are outlined below.   
Qualitative: quality was limited by the lack of reported methodological detail in the two 
studies resulting in predominantly ‘can’t tell’ ratings. 
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Quantitative descriptive: only one of the nine studies met criterion two, ‘Is the sample 
representative of the population under study?’.   
Quantitative randomized controlled: only one of the four studies met criterion one, ‘Is there a 
clear description of the randomization (or an appropriate sequence generation)?’. 
Quantitative non-randomized: No study in this group had a control group making criterion 
three relating to comparability of groups not applicable. Only one of the four studies met 
criterion one ‘Are participants (organizations) recruited in a way that minimizes selection 
bias?’.   
Laxative Types 
The type of laxatives used by participants is outlined in seven quantitative descriptive 
studies  (Böhmer et al., 2001, Connor et al., 2014, Joos et al., 2016, van der Heide et al., 
2009, Van Winckel et al., 1999, Veugelers et al., 2010, Ganesh et al., 1994).  The highest 
quality study found that the most commonly used laxatives in children with severe 
generalized cerebral palsy mostly living in the family home were disaccharide (24.3% of 152 
children) and polyethylene glycol (macrogol) (13.2% of 152 children) (Veugelers et al., 
2010).  The most recent study found that macrogol combinations were received by 48.1% of 
156 institutionalised adults and children with profound intellectual disability using enteral 
feeding tubes in Belgium, the second most common medication received by this population 
after the anti-epileptic valproic acid (Joos et al., 2016).  Macrogol combinations were also the 
most frequently prescribed laxative for adults and children with profound intellectual and 
multiple disabilities (PIMD) living in institutions in the Netherlands (30% of 254 people with  
PIMD) followed by bisacodyl (29%) and lactulose (14%) (van der Heide et al., 2009). An 
earlier study in England found only four of 181 people living in community based care homes 
(2.2%) to be taking macrogol, with the most frequent being lactulose (46 of 181; 25.4%) and 
senna (27 of 181; 14.9%) (Connor et al., 2014).   
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A number of people with intellectual disability receive rectal laxatives, enemas or 
suppositories, with figures reported being 22.4% of 152 children with severe generalized 
cerebral palsy living mainly in the family home (Veugelers et al., 2010), 5.5% of 181 
residents living in a community based care homes in one trust area (Connor et al., 2014), 10% 
of 215 adults and children with intellectual disability living in institutions (Böhmer et al., 
2001), 57.9% of 38 adults with profound intellectual disability in one institution (Ganesh et 
al., 1994), at least 10% of 254 adults and children with PIMD in institutions (10% received 
sodium phosphate enemas, 3% docusate sodium but it is not possible to tell if these figures 
are mutually exclusive)  (van der Heide et al., 2009), and 12.4% of 420 adults and children 
with intellectual disability living in institutions (Van Winckel et al., 1999).   One study found 
that in one institution, despite adult men and women having similar disabilities, most of those 
receiving suppositories were women and it is suggested that this may reflect different practice 
on the wards (Ganesh et al., 1994).  Manual evacuation was also reported for 6.7% of 215 
adults and children living in institutions (Böhmer et al., 2001) and 9.2% of 152 children with 
severe generalized cerebral palsy mostly living in the family home (Veugelers et al., 2010). 
Where reported, use of multiple laxatives was common.  Of 149 adults and children 
with constipation living in institutions, 34.2% used two laxatives and 9.4% used three 
laxatives (figures include sodium phosphate enemas) (Böhmer et al., 2001).  Of 65 
community based care home residents taking laxatives in one trust area, 30.8% used two 
laxatives, 15.4% used three laxatives, and 4.6% used more than three (figures include 
enemas/suppositories) (Connor et al., 2014).    
Laxatives were not necessarily effective, with efficacy being variable in adults and 
children in institutions (Böhmer et al., 2001).  In a randomized crossover studying comparing 
laxatives to abdominal massage for adults in an institution or associated group homes, 43% of 
participants showed no improvement in colonic transit time when on their usual laxative 
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regime compared to the baseline period with no treatment (Emly et al., 1998).  One study 
found that 36% of 83 children mainly living in the family home with severe generalized 
cerebral palsy taking laxatives nonetheless showed symptoms of constipation (Veugelers et 
al., 2010).  In this latter study, of the total sample of 152 children, water intake was below 
recommended amounts for 86.5% of children and daily intake of fibre was below 
recommended amounts in 53.2%, with six tube fed children receiving no fibre at all.   
Interventions 
 Ten studies considered specific interventions for constipation.  Five of these evaluated 
dietary interventions (fibre), three of which were quantitative randomized controlled trials 
and two of which were non-randomized studies.  Four focused on abdominal massage: one 
was a quantitative randomized controlled trial; one was a non-randomized study; and two 
were qualitative studies obtaining feedback from those involved in implementing abdominal 
massage.  One non-randomized study looked at the efficacy of polyethylene glycol 3350 plus 
electrolytes (PEG+E).   
Dietary Interventions  
All dietary interventions reported in this review considered the effect of dietary fibre.  
The dietary intervention study with the highest MMAT score looked at the effect of the 
dietary fibre glucomannan on chronic constipation in neurologically impaired children 
(Staiano et al., 2000).  After 12 weeks of treatment with glucomannan, no side effects were 
reported and there were significant increases in stool frequency, significant reductions in 
laxative or suppository use, significant improvements in stool consistency, and significant 
reductions in episodes of painful defecation.  With placebo, none of these improvements were 
found.  However, neither glucomannan nor placebo had a measurable effect on total and 
segmental transit times.   
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One study investigated the effect of adding fibre (All-Bran®) to the breakfast of orally 
fed children living in a large institution (Tse et al., 2000).  Baseline fibre intake was found to 
be very low at around 2 g/day. Increasing fibre intake to 17 g/day (stage 1) led to a significant 
reduction in laxative use.  Increasing fibre intake further to 21 g/day (stage 2) led to a further 
reduction in the use of laxatives but there was no statistical significance between stage 1 and 
stage 2 of fibre supplementation.  
A further study found that fibre and fluid intake were below recommended amounts in 
adult training centre residents with bowel dysfunction, and controlled trials of a dietary 
supplement with approximately 7g additional fibre per day were subsequently undertaken 
(Capra and Hannan-Jones, 1992).  In the treatment group, enemas reduced from seven to five 
per fortnight and the overall texture of bowel movements improved.  Controls had no 
reduction in enemas (eight per fortnight), and experienced a significant reduction in the 
number of bowel motions and a worsening of stool texture. It should be noted that the dietary 
supplement also included the natural laxative dihydroxyphenyl isatin (found in prunes) which 
stimulates intestinal motility.  
One crossover study looked at tolerance of a paediatric adapted enteral formula with 
added soy fibre in children (mostly in foster care) receiving enteral feeding and using 
elimination aids (Tolia et al., 1997).  The formula with added fibre was well tolerated and 
there was a slight trend towards decreased use of elimination aids to induce a bowel 
movement during the fibre supplemented formula phase (i.e. more with spontaneous 
defecation).   
One study looked at the effects of three levels (fibre free, 12 to 20 g/day, 18 to 25 
g/day) of purified dietary fibre (soy polysaccharide) over a one year period on stool 
frequency, size and consistency in non-ambulatory, enterally fed youths with chronic 
constipation in an institution (after the study commenced five of the 11 participants were 
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found to experience loose stools as a consequence of chronic antacid medication) (Liebl et 
al., 1990).  Whilst the use of elimination aids was not reduced by either level of fibre, fibre 
was found to improve bowel function, with increases in daily stool frequency, stool moisture, 
wet stool weight and dry stool weight.  
 
Abdominal Massage 
In relation to abdominal massage, the study with the highest MMAT score used a 
randomised cross-over design to compare abdominal massage (five times a week for 20 mins) 
for adults in an institution or associated group homes with the participant’s usual laxative 
regime (Emly et al., 1998).  The effects of laxative and massage therapy for this group (48% 
of whom always required an enema to defecate) were not demonstrably different. However, 
abdominal massage had no side effects and structured interviews with keyworkers provided 
anecdotal evidence of increased tolerance to touch and improved behaviour and 
communication, while the period of one-to-one contact was believed to enhance the 
therapist/nurse-patient relationship.  
  In a service development initiative in one area of England, parents of children with 
physical and learning disabilities or complex needs living in the family home were trained 
and asked to complete abdominal massage for 20 minutes a day over a 6 week period and 
record outcomes (Bromley, 2014).  Results reported a wide range of quality of life 
improvements, including relief in symptoms of constipation (87.5%), increase in optimal 
stool type from 13% to 59%, reduction in laxative medication (58%), improved dietary intake 
(41%), and improved sleep pattern (37%). Qualitative data indicated positive experiences 
described by parents which included enhanced parent-child relationships.  The estimated 
annual cost saving from reduced laxative use was £1,322.03 whilst the estimated cost of 
education/training was £35.20 per family.  However, parents were provided with information 
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to increase their understanding of constipation and it is not clear to what extent positive 
results can be attributed solely to abdominal massage, for example some parents reported the 
introduction of toileting plans during the 6 week period.   
In an area of England where abdominal massage was implemented as part of a total 
bowel management programme, a questionnaire consisting of open ended questions was sent 
to families and carers to gain feedback on the experiences of adults and children with 
intellectual disability living in the community and their carers with regards to abdominal 
massage (Connor et al., 2014).  All feedback was positive and included ease of learning and 
implementation; bowel movement changes; improvements in pain, mood or behaviour; 
reduction of laxatives; and providing opportunities to develop the therapeutic relationship. 
However, as abdominal massage was part of a total bowel management programme which 
included attention to diet, fluid intake, mobility, and toilet regimen and positioning, it is again 
not clear to what extent positive results can be attributed solely to abdominal massage.  
Finally, an audit 18 months after the introduction of abdominal massage in one area of 
England used a questionnaire with open ended questions to look at the views of nurses and 
healthcare workers involved in its implementation in a community based home for adults 
with profound physical disability and intellectual disability (Emly et al., 2001).  There was a 
change in clinical practice and staff attitudes to bowel management, and increased confidence 
and knowledge of bowel care including more awareness of faecal impaction risk.  There was 
greater emphasis on diet, fluid intake, exercise and passive movement.   Initial anxieties 
regarding the withdrawal of laxatives were unfounded.    
Medication 
As noted previously, two studies relating to medication were excluded (Staiano et al., 
1996, Frame et al., 1998) as the medications are not currently recommended.   One study 
based on retrospective analysis of hospital and pharmacy records examined the safety and 
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efficacy of polyethylene glycol 3350 plus electrolytes (PEG+E) for people with intellectual 
disability living in an institution who were treated with PEG+E for 24 months (Migeon-
Duballet et al., 2006).  There were significant increases in the mean number of stools per 
patient per month and episodes of diarrhoea (which was defined as 'a large number of stools 
not necessarily watery').  PEG+E was not associated with adverse effects on body weight or 
blood biochemistry values.  The total cost of laxatives per medical ward per year decreased 
from 3788.17 to 1767.39 Euros. However, whilst PEG+E was received by 54 participants, 
comparative data prior to the introduction of PEG+E was based on only 16 participants.   
Staff Related Issues 
Two quantitative descriptive studies provide information on staff related issues.  One 
study using information from records and interviews with staff explored diet and bowel 
management (not restricted to constipation per se, e.g. includes encopresis) in adults with 
intellectual disability who had moved from a hospital to community based staffed homes four 
years previously (Dickson et al., 2002).  An increase in bowel medication since moving to the 
community was associated with support by staff with no training, whilst a decrease was 
associated with support by staff with training.  Eighteen  staff  (41%) had any training in 
relation to diet and/or bowel management, 16 of whom had received a half-day course on 
basic nutrition from a dietician. None of the 44 participants received input from clinical 
psychology for behavioural management in relation to bowel control.  For 41 of the 44 
participants, support staff decided on their diet.   
A survey of registered nurses supporting people with intellectual disability in one 
major intellectual disability service provider in Ireland found good overall knowledge 
regarding the prevention and management of constipation (Marsh and Sweeney, 2008).  
However, there were some knowledge deficits, for example 33% incorrectly identified the 
best position for having a bowel movement as on the toilet with feet hanging freely above the 
Constipation Management 
 
floor.  In addition: only 64 (65%) correctly identified anticonvulsants as increasing 
constipation; 68 (69%) did not recognise diabetes as being associated with constipation; and 
whilst 81 (83%) recognised the need for 5 daily portions of fruit or vegetables, 65 (66%) 
correctly identified 2 litres of fluid a day as a minimum recommendation.     
Discussion 
Despite broad inclusion criteria, only 18 studies have been identified in relation to the 
management of constipation in people with intellectual disability.  ‘Interventions’ was the 
theme covered in the greatest number of studies, and these were restricted to five intervention 
studies involving dietary fibre, two intervention studies involving abdominal massage, two 
studies obtaining staff/carer feedback on abdominal massage, and one retrospective study of 
PEG+E.  ‘Laxatives types’ was also a common theme.  Only two studies considered service 
related issues such as staff knowledge and training.   
A number of studies including both institutional and family home based settings 
report below recommended levels of fluid and/or fibre intake in people with intellectual 
disability (Capra and Hannan-Jones, 1992, Tse et al., 2000, Veugelers et al., 2010), with the 
implication that improving intake may help with constipation.  Indeed, all four studies 
looking at the effect of dietary fibre interventions report some positive results relating to 
bowel function and/or laxative/enema use.  As suggested by Capra and Hannan-Jones (1992), 
even when there is chronic constipation, dietary intervention may be warranted.  However, as 
noted by Tse et al (2000), increasing dietary fibre intake will not solve the problem of 
constipation entirely since there are many other related factors, e.g. medication, physical 
inactivity, possible underlying defects in gut innervation and musculature (related to 
spasticity) and inadequate fluid intake due to oromotor dysfunction. Indeed, in one study 
children continued to be chronically constipated, having a prolonged intestinal transit time 
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despite improvements in outcomes such as stool frequency and painful defecation (Staiano et 
al., 2000).   
Whilst the effectiveness of abdominal massage was found not to be demonstrably 
different to that of laxatives for adults in one study (Emly et al., 1998), a number of positive 
outcomes have been attributed to abdominal massage, both in relation to relief in the 
symptoms of constipation and secondary outcomes such as improved sleep in children 
(Bromley, 2014), improvements in pain, mood or behaviour (Connor et al., 2014), and 
enhanced therapeutic relationships between those implementing and receiving the abdominal 
massage across a range of settings (Emly et al., 1998, Bromley, 2014, Connor et al., 2014). 
Concomitant reduction in laxative use for children living in the family home was also 
associated with cost savings (Bromley, 2014).  However, it is not clear to what extent positive 
results can be attributed solely to abdominal massage, with implementation being confounded 
by, for example, the introduction of toileting plans during the study period (Bromley, 2014) 
or by additional components of a total bowel management programme (Connor et al., 2014).   
A wide range of laxative types were reported to be used by people with intellectual 
disability (Böhmer et al., 2001, Connor et al., 2014, Joos et al., 2016, van der Heide et al., 
2009, Van Winckel et al., 1999, Veugelers et al., 2010), most frequently osmotic variants. 
Laxative polypharmacy was common (Böhmer et al., 2001, Connor et al., 2014).   A number 
of people with intellectual disability also received rectal laxatives, enemas or suppositories, 
with figures reported ranging from 5.5% of residents in community based care homes 
(Connor et al., 2014) to 57.9% of adults with profound intellectual disability in one institution 
(Ganesh et al., 1994).  Manual evacuation was also reported for a small proportion of people 
with intellectual disability (Böhmer et al., 2001, Veugelers et al., 2010).  Laxatives were not 
effective for all people with intellectual disability (Böhmer et al., 2001, Emly et al., 1998, 
Veugelers et al., 2010).  However, only two studies provides information on laxative use for 
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those living in community based settings (Connor et al., 2014, Veugelers et al., 2010) and 
older institutional based studies may report practices that are no longer common.   
The one study specifically on laxative effectiveness identified suggests that PEG+E is 
safe and effective in the clinical management of constipation in people with intellectual 
disability in an institutional setting (Migeon-Duballet et al., 2006).  In relation to the general 
population, PEG received a ‘grade A’ recommendation for improving stool frequency and 
consistency (Zurad and Johanson, 2011).   Two recent studies involving institutional settings 
found that macrogol (polyethylene glycol) combinations were the most commonly prescribed 
laxative for people with profound intellectual disability (Joos et al., 2016, van der Heide et 
al., 2009). However, care should be taken when using PEG in people who have dysphagia 
where liquids are thickened with starch, as a precipitous loss of thickening has been found to 
occur to liquids when PEG is added, although PEG may be compatible with xanthan gum 
based thickeners (Carlisle et al., 2016). 
Support staff have the potential to play a vital role in the management of constipation 
in people with intellectual disability, for example they are often in control of the diet people 
with intellectual disability receive (Dickson et al., 2002). However, only two studies provide 
any information in relation to this theme.  For registered nurses supporting people with 
intellectual disability in Ireland, some deficits have been found in knowledge regarding the 
prevention and management of constipation (Marsh and Sweeney, 2008) and it is plausible 
that knowledge deficits could be greater in non-nursing support staff.  Staff training in 
relation to diet and/or bowel management has been found to be associated with a decrease in 
bowel medication for adults following a move to the community from a hospital setting, with 
increases being associated with support by staff with no training (Dickson et al., 2002).  
Dickson et al note that training may play a role in two ways: making staff alert to the 
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requirements of a healthy diet in relation to bowel management; and making staff alert to the 
need to refer clients to GPs for monitoring and adjustment of medication.   
Given how common constipation is in people with intellectual disability and the 
impact it can have on health and quality of life, the lack of research on the management of 
constipation is surprising.  There is a particular lack of research in relation to managing 
constipation in community based settings.  The lack of research and lack of comparison of 
interventions against each other mirrors the findings of a systematic review of management 
for those with central neurological disease (Coggrave et al., 2014).  Many topics remain to be 
the subject of research for people with intellectual disability and constipation including: the 
role of toileting and the toileting environment; the impact of educating staff, carers and 
people with intellectual disability about constipation; the impact of diet, exercise, fluid 
intake, or other service related initiatives to try to reduce constipation; and whether learning 
disability nurses could take a role in education regarding constipation. In addition, no 
research has been done with people with intellectual disability in relation to approaches to 
managing constipation including probiotics (Dimidi et al., 2014); transcutaneous electrical 
stimulation (TES) (Hutson et al., 2015); and physiotherapeutic methods of connective tissue 
manipulation and Kinesio Taping (Orhan et al., 2016).   
Behavioural approaches also warrant further research.  It has been suggested that 
classical and operant treatment methods appear to be the best supported interventions for 
encopresis, soiling and constipation in children and adults with developmental disability 
(Matson and Lovullo, 2009).  One study (which did not meet the inclusion criteria for this 
review) used a behavioural approach involving prompted toilet-sitting after meals, rewards 
for appropriate evacuation and increased fibre in four people with intellectual disability who 
suffered from chronic constipation, faecal impaction, soiling and were long term users of 
elimination aids (Smith et al., 1994).  Training resulted in near normal bowel function, 
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although training time was long and it was unclear which elements of the programme were 
essential to success.  The authors note that the work is costly due to the intensive and 
prolonged nature of the programme and the field is vastly under resourced.  One study in this 
review found that no people with intellectual disability received clinical psychology input for 
behavioural management in relation to bowel control (Dickson et al., 2002).   
Numerous clinical guidelines for managing constipation exist, with one international 
study identifying 22 clinical practice guidelines for constipation (Tian et al., 2016).  Some 
specifically exclude those with developmental delay (Tabbers et al., 2014). In England and 
Wales, NICE clinical guidelines for managing constipation in children exist (NICE, 2010) 
and these specifically state that assessment and management for those with physical 
disabilities (such as cerebral palsy), Down syndrome or autism should happen in the same 
way as is recommended for all children and young people (NICE, 2010, p 4-5).  Clinical 
knowledge regarding constipation in adults has also been summarised by NICE (NICE, 
2015).  However, no clinical guidelines appear to be available specifically for people with 
intellectual disability.   
It has been suggested that national clinical guidelines on constipation in adults with 
intellectual disability could be formulated so that healthcare workers would have an 
evidence-based framework to consult (Cockburn-Wells, 2014).  In one area of England, 
failure of current practice to effectively manage constipation led a multi-professional group 
of health care practitioners to review evidence and develop a clinical guideline for the 
management of chronic constipation of adults within the community including people with 
intellectual disability (Emly and Rochester, 2006) and this guideline has recently been 
updated (Emly and Marriott, 2017).  The guideline recommends a multi-faceted treatment 
strategy involving several health care professionals in the holistic management process, with 
an individualized programme rather than relying solely on prescription of laxatives.  Early 
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indications on use of the guideline with people with intellectual disability suggest that 
holistic, individualised bowel management programmes can reduce laxative use and nursing 
interventions and lead to improved quality of life (Emly and Rochester, 2006).     
Raising awareness of the issue of constipation in people with intellectual disability 
may lead to further efforts within services to address the management of constipation. For 
example, following an event on constipation by the Public Health England Learning 
Disabilities Observatory, a group was formed in Central Midlands which aims to improve 
awareness and treatment of constipation in people with intellectual disability (Whait, 2016).  
Böhmer et al (2001) note that until research provides clear answers as to how to 
manage constipation in people with intellectual disability, the principles for treatment are the 
same for individuals with intellectual disability as for the general population.  As a basic 
principle, it has been suggested that bowel management should begin with the “eight keys to 
bowel success” prior to developing an individualised bowel programme: physical exercise, 
high fibre intake, high fluid intake, consistent habit time, an upright position on toilet or 
commode, privacy, medication management, and patient and family education (Weeks, 
Hubbartt, & Michaels, 2000). Whilst early studies on constipation management for people 
with intellectual disability focused on specific elements of constipation management (e.g. 
dietary fibre), a recent study considers the management of constipation using abdominal 
massage in the context of a total bowel management programme (Connor et al., 2014).  As 
noted by Emly et al (1998), maximum benefit of both laxative and abdominal massage 
interventions will be obtained only within a more general individualised programme of bowel 
management that addresses additional factors such as diet, exercise and toileting.  Further 
research is required to support early indications that an integrated bowel management 
programme may be appropriate for managing constipation in people with intellectual 




A limitation of this review is the potential loss of information from two main sources. 
First, the review has not considered how studies regarding approaches to managing 
constipation in other populations may be applicable to people with intellectual disability.  For 
example, a study involving children and adults with quadriplegic cerebral palsy looked at a 
nursing intervention using non-pharmacological conservative therapy (intestinal massage; 
abdominal press; increase in water intake; increase in the use of vegetable oils in main meals; 
increase in the consumption of laxative fruits, leafy vegetables, and high fibre foods; and 
decrease in the consumption of constipating foods) (Faleiros and de Paula, 2013).  Complete 
or partial improvement of constipation was observed in 90% of the patients, laxative use was 
reduced and there were improvements in sleep patterns, appetite, and mood (Faleiros and de 
Paula, 2013).  Second, the review does not consider research relating to specific syndromes 
associated with intellectual disability such Rett syndrome. In addition, whilst studies were 
identified from a range of countries, the review is restricted to English language publications.  
No studies were identified from low and middle income (LAMI) countries. Finally, all data 
was extracted by one reviewer and checked for accuracy and completeness by a second 
reviewer.  Whilst this is an accepted minimum (Centre for Reviews and Dissemination, 
2009), extraction of data by two reviewers independently would have reduced the possibility 
of errors.   
Conclusion 
It is clear that the main management response to constipation in people with intellectual 
disability is laxative use but this is not effective for all people with intellectual disability.  
Awareness of the issue of constipation management in people with intellectual disability 
needs to be raised.  An improved evidence base with robust high quality studies is required to 
better understand what works well in managing constipation in people with intellectual 
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disability.   This should include research to test the suggestion that the best way to manage 
constipation for people with intellectual disability is an individualised, integrated bowel 
management programme.  In the meantime, services should consider adopting the guidelines 
for the management of chronic constipation of adults within the community (Emly and 
Marriott, 2017) which are available online at 
https://www.ndti.org.uk/uploads/files/ConstipationGuideline2016.pdf.  In addition, a recent 
report provides information on reasonable adjustments that can be made for managing 
constipation in people with intellectual disability (Marriott and Emly, 2016).  The ideas, 
information and examples of good practice in relation to managing constipation provided 
within these resources should help services improve provision for this highly prevalent 
condition and potentially reduce ill health and deaths associated with constipation in people 




Example of Database Specific Search Terms (Medline) 
Limiters: Jan 1990 – 2017; English language.   
( ( (MH "Constipation") OR (MH "laxatives") OR (MH "fecal impaction") OR ( TI 
constipat* OR TI fecal OR TI faecal OR TI laxative* OR TI defecat* OR TI defaecat* OR TI 
bowel OR TI colon* OR AB constipat* OR AB fecal OR AB faecal OR AB laxative* OR 
AB defecat* OR AB defaecat* OR AB bowel OR AB colon*)) ) AND ( ( (TI ( learning N1 
(disab* or difficult* or handicap*) ) OR TI ( mental* N1 (retard* or disab* or deficien* or 
handicap* or disorder*) ) OR TI ( intellectual* N1 (disab* or impair* or handicap*) ) OR TI 
development* N1 disab* OR TI ( multipl* N1 (handicap* or disab*) ) OR TI "Down* 
syndrome" OR (MH "Developmental Disabilities") OR (MH "Intellectual Disability") OR 
(MH "mentally disabled persons")) OR (AB ( learning N1 (disab* or difficult* or handicap*) 
) OR AB ( mental* N1 (retard* or disab* or deficien* or handicap* or disorder*) ) OR AB ( 
intellectual* N1 (disab* or impair* or handicap*) ) OR AB development* N1 disab* OR AB 
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Related Focus Design 
Key sample features 













US Dietary fibre Within subjects repeated 
measures with 3 levels 
of purified dietary fibre 
source.  i 1-60 days fibre 
free liquid feeding, ii 
days 61-120 & 121-300 
added 5g/240ml purified 
soy polysaccharide,  iii 
days 301-360 Soy 
polysaccharide 
concentration increased 
by 50%.   
Non-ambulatory severely 
developmentally 
disabled youths resident 
at a centre for the 
developmentally 
disabled, all enterally fed 
& chronically constipated 
(child; institution) 
11 7-17  
(ns) 
46 Stool frequency; 
size and 
consistency; wet 
and dry weight 
from total stool 
collections (last 
10 days of each 
period, and 2 x 
10 days period 
4) 
Suppositories were given every 3 days if no BM.  Use of elimination 
aids not reduced by either level of fibre.  The second fiber addition 
significantly increased mean (SD) daily stool frequency from 0.6 (SD 
0.2) during the fiber-free diet to 1.1 (SD 0.5). The first addition of fiber 
compared to the fiber-free diet significantly increased stool moisture 
from 70% (SD 7%) to 76% (SD 8%) and wet stool weight from 30 (SD 
13) g/day to 53 (SD 21); mean stool weight during days 351 to 360 
was 87 (SD 45) g/day. Daily dry stool weight significantly increased 
with the second fiber addition. Soy polysaccharide fiber improved 





Australia Fibre & fluid 
intake; effect of 
modifying dietary 
fibre on bowel 
function 
3 x controlled trials: 2 
week baseline, 2 week 
intervention, 2 week 
post-intervention.  
Intervention a dietary 
supplement with approx 
7g additional fibre per 
day as a mixture of 
soluble and insoluble 
fibres plus natural 
laxative dihydroxyphenyl 
isatin which stimulates 
intestinal motility 
Adult training centre 
residents with bowel 
dysfunction; 62.2% 
immobile; meals from 
central kitchen 
(adult; institution) 
37 19-72 (ns) 51 Number BM, 
texture, number 
of suppositories 
or enemas used 
Estimates of fibre and fluid intakes yielded mean intakes of 18.6g fibre 
per day (range 14–23g) (current recommendations at the time were 
25-30g per day) and 2.2 litres of fluid (range 1.8–2.4 litres) - this 
included approx 1 litre fluid in food (recommendation at the centre 
was to give 2-2.5 litres fluid a day above that found in food).  
Improving fibre and fluid intake may help with constipation 
management and prevention.   Controls had no reduction in enemas 
(8 per fortnight), treatment group reduced from 7 to 5 per fortnight.  
For treatment group overall texture of BM improved.  Those not 
receiving the supplement experienced a significant reduction in the 
number of BMs and a worsening of stool texture, while those receiving 
the supplement did not. Results suggest that, even when there is 





Wales Suppository use Audit Adults with profound ID 
living in one institution 
(adult; institution) 





50 % receiving 
suppositories 
regularly 
22/38 (57.9%) were regularly taking suppositories for constipation.  18 
of the 22 were women despite men and women having similar 
disabilities.  Suggested that difference in use of suppositories 
between men and women may be because they are on different 














crossover study. During 
two phases of each 4-
week period of the 
crossover study, 
subjects were fed 
Pediasure® either with 
(PS10) or without (PS) 
Children receiving 
enteral nutrition 
supplements for >80% of 
energy requirements.  All 
had difficulty with 
defecation requiring 
elimination aids for over 
6 months duration.  Most 
in foster care 












No differences in tolerance, stooling, growth, or biochemical 
measurements between the feeding regimens, in 11 children 
completing this phase of the study. Slight trend towards using less 
elimination aids to induce a BM during fiber supplemented formula 
phase (i.e. more with spontaneous defecation):  2 of 11 (18%) 
participants needed no elimination aids when using PS compared to 3 
of 11 (27%) using PS10.   Pediasure with fiber well tolerated in 
children with developmental disabilities and possibly decreased use of 










Related Focus Design 
Key sample features 








measures Management Related Results 
10g/l dietary soy fiber 
(soy polysaccharide).  
Following completion of 
the crossover study, 
subjects were fed 
Pediasure® with fiber for 
an additional 2 months. 













abdominal massage (x5 
a week for 20 mins) and 
usual laxative regime.  
Group i massage first, 
group ii laxatives first. 16 
days baseline with no 
treatment, and two 7 
week treatment phases 
separated by one week 
washout.   Also 
structured interviews 
with key worker  
Adult residents of an 
institution or 2 
associated group 
homes; profound or 
severe ID, with CP or 
genetic conditions 
associated with 
abnormal muscle tone, 
regular use of 
laxative/enemas for 12+ 
months before trial. 90% 
on laxative/enemas 5+ 
years;  48% always 
required enema to 
defecate 
(adult; institution & 2 
group homes) 




















Median total colonic transit time was 183 hours for baseline phase 
and 159 hours for all treatment phases. No evidence of any 
statistically significant treatment differences between laxative and 
massage therapy for right, left or rectosigmoid segments either 
separately or in total. Analysis of secondary outcome measures also 
failed to find any treatment preferences.  The effects of laxative and 
massage therapy within this environment were not demonstrably 
different.  43% of subjects showed no improvement in colonic transit 
time over baseline while on their previous laxative regimen adding 
weight to clinical concern about long-term laxative dependency. 
Results reveal grossly abnormal colonic transit times of the study 
population at all times.  Anecdotally, evidence from structured 
interviews included reports of increased tolerance to touch and 
improved behaviour and communication, while the period of one-to-












descriptive study using 
structured interviews 
Patients with moderate 
to profound ID living in 
institutions 
(adult 73%, child 27%; 
institutions) 
420 2-72  
(ns (ns); 29) 
63 Laxative use Enemas used chronically by 12.4% (52/420) of the residents, of whom 
23% (12/52) needed an enema before each defecation. Seventy-nine 
percent (41/52) used enemas in combination with oral laxatives. Fifty-
eight percent (28/52) used phosphate enemas (O), 27% (14/52) 
sodium lauryl sulfate (O) or sodium docusate (S), 13.5% (7/52) 
glycerine (O) and 5.5% (3/52) isotonic saline (O). In 70% (40/52), 
enemas were given after a predetermined number of days without 





Italy Dietary fibre Randomly assigned to 
double-blind treatment 
with either glucomannan 
(n = 10) or placebo (n = 
10) for 12 weeks 
following a 2 wk baseline 
period.  Before patients 
entered the treatment 
period, impacted feces 
were removed with 
Children with severe 
neurological damage 
(brain damage due to 
perinatal or prenatal 
hypoxia) and chronic 
constipation (at least one 
year duration) & most 
evacuation not possible 
without enema.  All fed 
semi-liquid diet by mouth 
20  ns  
(5.7 (4.2); ns) 







use.   
1 child withdrew leaving 10 placebo, 9 glucomannan. No side effects 
reported, and treatment well-tolerated in both groups.  After 12 weeks 
of treatment, glucomannan significantly increased stool frequency 
from 1.8 ± 0.2 stools/wk to 3.8 ± 0.9 stools/wk (p < .01).  Stool 
frequency did not increase with placebo (from 2.3 ± 0.7 stools/wk to 
2.0 ± 0.6 stools/wk). Laxative or suppository use significantly (p < .01) 
reduced by glucomannan (from 1.9 ± 1.3 doses/wk to 0.3 ± 0.5 
doses/wk) but not by placebo (from 2.5 ± 0.5 doses/wk to 2.1 ± 0.4 
doses/wk).  Clinical scores of stool consistency were significantly 










Related Focus Design 
Key sample features 








measures Management Related Results 
repeated enemas for 2 
or 3 days.  
(child; ns) significantly reduced by glucomannan (p < .01) but not by placebo. 
However, neither glucomannan nor placebo had a measurable effect 
on total and segmental transit times. Glucomannan improves stool 












Pilot study. Dietary 
intake assessed over 3 
days.  Within subjects 
repeated measures to 
look at effect of adding 
fibre to diet.  All-Bran® 
added in breakfast: 
stage 1 = 20 days 17g 
fibre; (followed by 10 day 
normal diet); stage 2 = 6 
weeks 21g fibre 
Children with severe 
developmental 
disabilities in large 
residential institution, 
orally fed, medically 
stable 
(child; institution) 
20 3-17  
(ns (ns); ns) 






do not mention 
BM just 
laxatives) 
Baseline fibre intake very low at around 2 g/day. Mean number of 
laxatives required per week per child decreased significantly from a 
baseline value of 1.22 (about 5 laxatives/month) (SD 0.36) to 0.90 
(about 3. 5 laxatives/month) (SD 0.75) in the first stage, and 0.71 
(about 3 laxatives/month) (SD 0.40) in the second stage.  No 
significant difference between the two stages of fibre supplementation 












Prospective collection of 
daily data by nursing 
staff 
People with ID with IQ < 
50 (moderate to 
profound ID) from 4 
institutions 
(adult & child (% ns); 
institutions) 








60 Frequency & 
type of laxative; 
use of manual 
evacuation 
Of 149 (69.3%) with constipation, 57.6% used bisacodyl (S) or 
magnesium oxide (O), 38.6% used lactulose (O), 13.4% used sodium 
lauryl sulphoacetate/sodium citrate/sorbitol (O) and 9.6% used sodium 
phosphate enemas (O). 51 (34.2%) used two of the above in 
combination, and 14 (9.4%) used 3 of the above in combination.   
Manual evacuation of faeces by nurses in 10 patients (6.7%).   There 
was a high frequency and variety in laxative treatment with variable 









Audit took place 18 
months after introduction 
of abdominal massage 
for clients unsuccessfully 
managed on laxatives.  
Questionnaire with 10 
open-ended questions 
4 RNMHs, 6 healthcare 
workers  involved in 
implementation of 
abdominal massage 
programme in NHS 
group home 
(staff supporting adults; 
community home) 
10 ns ns Responses to 10 
open ended 
questions  
There was a change in clinical practice and staff attitudes to bowel 
management, increasing commitment to the change in practice, 
increased confidence & knowledge of bowel care.  More aware of 
faecal impaction risk.  Initial anxieties on the withdrawal of laxatives 
unfounded.  Greater emphasis on diet, fluid intake, exercise and 





Scotland Diet & bowel 
management 4 
years after move 
from hospital to 
community; staff 
training 
Retrospective analysis of 
records & cross-
sectional semi-structured 
interview with staff on 
duty at time of data 
collection 
People with ID who had 
moved from a hospital to 





44 ns  
(49.5 (10.9); 
ns) 





12/44 received no bowel medication. Since moving to community, 14 
(32%) had some decrease in bowel medication, 9 (20%) an increase.  
Age, gender, ambulancy, input from dietician, receiving special diet or 
deciding own diet not associated with changes in bowel medication.  
Increase in medication associated with support by staff with no 
training.  Decrease in medication associated with support by staff with 
training. 41/44 support staff decided on diet.  0/44 received input from 
clinical psychology for behavioural management in relation to bowel 
control.  18 (41%) of staff had any training in relation to diet and/or 










Related Focus Design 
Key sample features 








measures Management Related Results 
nutrition from dietician. 1 had training relating to gastrostomy tube 
feeding, 1 eating, drinking, swallowing difficulty.     No association 










PEG 3350 plus 
electrolytes 
(PEG+E) 
Retrospective analysis of 
records & hospital 
pharmacy records.  
Participants treated with 
with PEG+E (1-3 
sachets a day) for 24 
months.  Data compared 
with that of 21 months 
preceding PEG 
introduction 
Residents at specialist 
unit with severe 
intellectual & physical 
disability; less than one 
stool per 48 h and/or 
evacuation problems; 
receiving laxatives 
























Mean number of stools per patient per month increased significantly 
from 12.4 (SD 3.4) to 24.9 (SD 6.3), episodes of diarrhoea increased 
significantly from 0.1 (SD 0.1) to 6.3 (SD 2.9), not associated with 
adverse effects on body weight or blood biochemistry values, total 
cost of laxatives per medical ward per year decreased from 3788.17 









people with ID 
Survey using self 
completion questionnaire 
RNs supporting people 
with ID.  166 RNs 
identified, 59% (n=98) 
response rate 
(nurses in one ID health 
service provider 
supporting ns age; ns 
settings)  
98 ns ns Number of 
correct 




Overall accuracy of 64% suggests good overall knowledge in 
prevention and management of constipation.  Knowledge deficits 
included: only 64 (65%) correctly identified anticonvulsants as 
increasing constipation; 68 (69%) did not recognise diabetes as being 
associated with constipation; and whilst 81 (83%) recognised the 
need for 5 daily portions of fruit or vegetables, 65 (66%) correctly 
identified 2 litres of fluid a day as a minimum recommendation.  33% 
incorrectly identified the best position for having a BM as on the toilet 










Retrospective analysis of 
medical & pharmacy 
records 
People with profound 
intellectual and multiple 
disabilities (PIMD)  living 
in 8 facilities for people 
with ID 
(adult 93%, child 7%; 
institutions) 
254 6-82  
(ns (ns); 49) 
46 Laxatives 
prescribed in 
prior 12 months 
226 (89%) prescribed medication in prior 12 months.  Most frequently 
prescribed were laxatives (165/254, 65%). Constipation was a 
registered health problem in 68% (n = 112/165; 95% CI 61–75%) of 
cases where laxative prescribed.   Laxatives prescribed: macrogol 
PEG) combinations (O) 76/254 (30%); bisacodyl (S) 73/254 (29%);  
lactulose (O) 36/254 (14%); lactitol (O) 31/254 (12%); sodium 
phosphate (enema) (O) 25/254 (10%); Isphagula (B) 9/254 (4%);  
docusate sodium (enema) (S) 7/254 (3%); All medications prescribed 












observational study with 
diary completion over 
two weeks 
Children with severe 
generalized CP & ID, 
most living at home 
(child; family home 80% 
(remainder ns)) 
152 2-18  
(9.6 (4.6); ns)  
51 Laxative use, 
fibre and fluid 
intake 
Prevalence of constipation 57% (95% CI 45%, 69%).  Of the 152 
children, 54.6% used any laxative, 13.2% polyethylene glycol (O), 
24.3% disaccharide (O), 7.9% other.  Rectal laxative use 22.4%.  
Manual disimpaction 9.2%.   Of 83 children using laxatives, 36% 
nonetheless showed symptoms of constipation. Dietary intakes below 
the recommended amounts for water in 86.5% and in 48% of children 
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measures Management Related Results 
intake of fibre was below recommended amounts in 53.2%, more than 
6g below the recommended minimum in 41%, and 6 children (all tube 
fed) received no fibre at all. However, no significant relation between 








initiative with pre/post 
data collection.  Parents 
trained & asked to 
complete abdominal 
massage for 20 mins a 
day and recorded 
outcomes over 6 week 
period 
All had physical disability 
and learning disabilities 
or complex needs and 
chronic constipation (> 8 
weeks)  
(child; family home) 
25 ns (inclusion 
criteria age 3 
mths to 19 
yrs) 





service use & 
quality of life, 
laxative use 
Results report a wide range of quality of life improvements including 
relief in symptoms of constipation (87.5%), reduction in laxative 
medication (58%), improved dietary intake (41%), improved sleep 
pattern 37%. Qualitative data indicate positive experiences described 
by parents which include enhanced parent-child relationships.  
Optimal stool type 4 increased from 13 to 59%.  Annual cost saving 
for 10 who had reduced laxative use estimated to be £1,322.03.  Cost 






England Audit of bowel 
care 
Audit People with ID living in 
care homes in one trust 
area 
(age ns; community care 
homes) 
181 ns ns Number & type 
of laxatives 
The audit included 181 residents, of whom 65 (36%) taking laxatives 
every day.  32 took one laxative (none of whom had enemas and/or 
suppositories), 20 took 2 (3 of whom had enemas and/or 
suppositories), 10 took 3 (4 of whom had enemas and/or 
suppositories) and 3 took more than 3 laxatives (for all of whom this 
included enemas and/or suppositories). Laxatives taken (and type) 
were: lactulose (O ) n=46; senna (S) 27; fybogel (B) 13; bisocodyl 
suppositories (S) 8; movicol (macrogol/PEG) (O) 4; husk (B) 2; 
glycerin suppositories (O) 2; bisocodyl (oral) (S) 1; microlax enema 










Questionnaire sent to 
families and carers to 
identify positive and 
negative aspects of 
abdominal massage 
implemented as part of a 
total bowel management 
programme  
Parents/carers involved 
in abdominal massage 
(carers of adults & 
children (% ns); 
community based) 
ns ns ns Open ended 
comments on 
use of abdominal 
massage 
All feedback on the introduction of abdominal massage was positive, 
including comments regarding: ease of learning & implementation; 
bowel movement changes; improvements in pain, mood or behaviour; 
reduction of laxatives.  No negative responses received.  Some 
reported that adopting abdominal massage provided further 
opportunity to develop the therapeutic relationship.  Positive case 





Belgium Medication used 






using medication records 
92.3% profound ID, all 
with EFT & receiving 
chronic medication 
through EFT, living in 
residential care facilities 
(adult & child (% ns); 
institution) 
156 2-80  




75% used drugs for constipation (2nd most frequent after antiepileptics 
at 78.2%).  2nd most common chronic drug used was macrogol (PEG) 
combinations (O) (48.1% of 156 participants).   Other laxatives noted 




Abbreviations: BM bowel movement; CP cerebral palsy; EFT enteral feeding tube; ID intellectual disability; PEG polyethylene glycol; PEG+E polyethylene 
glycol 3350 plus electrolytes;  ns not stated; NHS national health service; RNMH registered nurse (mental handicap).  Laxative types: B bulk forming; O 
osmotic; S stimulant.  MMAT types: Q qualitative; QRC quantitative randomized controlled (trial); QNR quantitative non-randomized; QD quantitative 
descriptive.   
 
 
 
